1 – Scheme overview

This External Quality Assessment scheme allows an evaluation of accuracy of the screening and assay methods for Fibrin and Fibrinogen Degradation Products (FDPs) in plasma.

The main marketed reagents are represented: quantitative automated methods and manual methods (screening and semi-quantitative testing of FDPs).

3 levels of concentration are tested.

Statistical reports are sent with supporting comments from the expert clinical biologists who coordinate the scheme.

2 – Assessment frequency

Number of investigations per year: 4
Number of control samples per investigation: 1 or 2
Number of samples per year : 6

3 – List of analytes assessed 

• Fibrin and fibronogen degradation products (FDPs)

4 – Description of the control samples

Lyophilized human control plasma (citrate) (samples to be resuspended in 1 mL of distilled water).